RTX-021

N/A

Report date: 2024/10/23 17:14:01

Base Information

Drug NameRTX-021
Drug Alias NameRTX-021RAY-002
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionGene transference
TargetsNot applicable
Therapy Area/IndicationsGeographic AtrophyStargardt Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRay Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesRay Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsGeographic AtrophyStargardt Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A